These complications may include an acute hemolytic transfusion reaction (AHTR), which is most commonly caused by ABO incompatibility. The patient may complain of pain, difficult breathing, fever and chills, facial flushing, and nausea.
Deaths associated with the transfusion of blood products have been directly linked to the following:
-acute or delayed hemolytic transfusion reactions,
-transfusion associated cardiac overload (TACO),
-transfusion related acute lung injury (TRALI),
-transfusion associated infections (viral, bacterial, parasitic)
-anaphylactic reaction (usually in an IgA-deficient recipient)
An allergic reaction to some of the cells or proteins in another persons blood
Transfusion reaction occurs when antibodies in the recipient's blood react to foreign blood cells introduced by the transfusion. The antibodies bind to the foreign cells and destroy them.
PYROGEN
death
An acute hemolytic transfusion reaction, with possible acute renal failure and death.
If a transfusion is given to a patient from a person with a different blood type, the immune system will attack those blood cells. This can cause a severe reaction in the patient, including shock to the immune system or death.
death
The person would eventually die if they received a water transfusion instead of a blood transfusion. It would most likely be a slow and painful death.
It produces what is known as a transfusion reaction. The blood cells burst open and cause pain, difficulty breathing, shakes, and sweating. If it is severe it can cause organ failure, cardiovascular collapse and death.
Yes. Failure to do so can result in death
It would actually be very harmful, and considering the already weakened state of someone who is in need of a transfusion, they could die. This is because his or her immune system would consider the Type B blood as an invader, and would try kill it. The Type B blood would also contain immune system cells, which would think that the Type A blood was invading it, so the Type B blood would kill the Type A blood cells. Thus, not only would the person not receive any benefit, but they would lose even more of their blood cells.
No because the person with type O has antibodies against the A antigens that are present of the red blood cells of people with type A blood. This means that the blood would clot in the arteries and cause blockaged possible resulting in death.
FDA guidelines require a temporary deferral of one year from date of transfusion for potential donors who have received blood products. This is to minimize the possibility of transfusion-transmitted diseases entering the blood supply. Though unlikely, there is a risk of transfusion-acquired infections with all blood component use. The one year deferral allows any potential disease to be present long enough to be detected by FDA-mandated screening tests.
Blood type O has antibodies against Type A, B and AB. Transfusion would result in a massive allergic reaction to your own blood and quick death.